Detalles de la búsqueda
1.
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy.
J Transl Med
; 12: 272, 2014 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253066
2.
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
J Transl Med
; 11: 38, 2013 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23402397
3.
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
J Transl Med
; 10: 178, 2012 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22931052
4.
Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO project.
Support Care Cancer
; 19(3): 381-9, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20204421
5.
Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.
BMC Cancer
; 10: 458, 2010 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735841
6.
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 10(1): 1918, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005869
7.
Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (
Oncologist
; 14(11): 1051-60, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19897535
8.
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 9(1): 11527, 2019 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31395900
9.
Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.
Oncotarget
; 9(2): 2876-2886, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29416820
10.
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
Lung Cancer
; 56(2): 263-71, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17298853
11.
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
Oncology
; 72(1-2): 17-26, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17998786
12.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
J Clin Oncol
; 23(22): 5138-47, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16009955
13.
Stop Flow in abdominal and pelvic cancer relapses.
Front Biosci
; 11: 1284-8, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16368515
14.
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Oncology
; 71(5-6): 341-6, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17855795
15.
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
BMC Cancer
; 6: 5, 2006 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16398939
16.
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Crit Rev Oncol Hematol
; 53(2): 133-9, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15661564
17.
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.
Clin Colorectal Cancer
; 5(3): 203-10, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16197624
18.
Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.
Anticancer Res
; 23(2C): 1917-22, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12820479
19.
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Sci Rep
; 4: 6828, 2014 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25370899
20.
Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer.
Breast J
; 14(6): 591-2, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19000050